Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.8 USD | +2.81% | -0.63% | -31.42% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.42% | 4.82B | |
-2.00% | 90.27B | |
-1.18% | 40.12B | |
-15.55% | 31.75B | |
+62.86% | 26.6B | |
-21.42% | 14.41B | |
-8.25% | 12.92B | |
-15.05% | 11.44B | |
-45.69% | 11.3B | |
+4.94% | 8.87B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Credit Suisse Lowers Apellis Pharmaceuticals' Price Target to $43 From $45, Keeps Neutral Rating